This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Editorial Universo
Soley, Jorge; Soley Climent, JorgeCase F-857Business Ethics and Corporate Social Responsibility, Finance, Innovation and ChangeEl caso analiza la inversión directa de una empresa mediana española en el Brasil. Explica las razones cuantitativas y cualitativas que apoyan esta decisión, los posibles escenarios de cash flow de cara al futuro, la problemática que puede surgir y cómo un cash flow negativo de la filial puede afectar al cash flow positivo de la matriz. Tiene en cuenta la solvencia financiera de la casa matriz que, aunque no es muy importante, ante la posibilidad...Starting at €8.20
-
Editorial Universo
Soley, Jorge; Soley Climent, JorgeCase F-857-EBusiness Ethics and Corporate Social Responsibility, Finance, Innovation and ChangeThis case analyzes a direct investment in Brazil by a medium-sized Spanish company. It outlines the quantitative and qualitative reasons behind this decision, the possible future cash flow scenarios, the issues that might arise and how negative cash flow in the subsidiary may affect positive cash flow in the parent company. It takes into account the financial solvency - though not very considerable - of the parent company, which, when presented w...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20